Corrections and clarifications: An article about a muscle growth drug trial contained an error in the print edition. The piece stated that participants given apitegromab alongside tirzepatide lost on average 1.6kg of lean mass, while those given apitegromab alongside a placebo lost on average 3.5kg of lean mass. However, as mentioned elsewhere in the article, the drug given alongside the placebo was actually tirzepatide. This mistake appeared only in the printed version of the article titled 'Drug could reduce muscle loss for those using slimming jab' published on 9 June, page 14, early editions.
Other Recently Amended Articles
Other recently corrected articles include: 'UK economy shrank by 0.1% in April as Iran war held back growth' and 'I’m hoping to meet a river goddess: a wild journey through Britain’s mythic waterways'.
How to Report Errors
Editorial complaints and correction requests can be sent to: guardian.readers@theguardian.com. You can also write to: Readers’ editor, Kings Place, 90 York Way, London N1 9GU, or leave a voicemail on +44 (0) 20 3353 4736.
Explore more on these topics: Corrections and clarifications.
